个人简历

Ph.D. Genetics and Cell Biology, Washington State University, 2001
B.S. Genetics and Cell Biology, University of Minnesota, 1996

近期论文

Albig, A.R. and Decker, C.J. (2001) The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Mol Biol Cell. 12(11):3428-38.
Albig, A.R. and Schiemann W.P. (2004) Fibulin-5 Antagonizes Vascular Endothelial Growth Factor (VEGF) Signaling and Angiogenic Sprouting by Endothelial Cells. DNA Cell Biol. 23(6):367-79
Albig, A. R. and Schiemann W.P. (2005) Identification and Characterization of Regulator of G-Protein Signaling 4 (RGS4) as a Novel Inhibitor of Tubulogenesis: RGS4 Inhibits MAP Kinases and VEGF Signaling. Mol Biol Cell. Feb;16(2):609-25
Schiemann, W.P and Albig, A.R. (2005) Fibulin-5 Function During Tumorigenesis. Future Oncology 1(1), 23-35.
Albig, A.R., Neil, J.R., and Schiemann, W.P. (2006) Fibulins 3 and 5 Antagonize Tumor Angiogenesis In vivo. Cancer Research. 66(5):2621-9
Albig, A.R., *Roy, T.S., *Becenti, D. J., and Schiemann, W.P. (2007) Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis. 10(3):197-216. * denotes undergraduate co-author
Albig AR, *Becenti DJ, *Roy TG, Schiemann WP. (2008) Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc Res. 2008 May;76(1):7-14 * denotes undergraduate co-author
Lee YH, Albig AR, Maryann R, Schiemann BJ, Schiemann WP. (2008) Fibulin-5 Initiates Epithelial-Mesenchymal Transition (EMT) and Enhances EMT Induced by TGF-{beta} in Mammary Epithelial Cells Via a MMP-Dependent Mechanism. Carcinogenesis. Dec;29(12):2243-51
Brown, L. J., *Crawford M. E., *Alawoki, M., *Sears, A., *Reida, T., *Torma, T., and Albig A.R., (2010). “Lipocalin-7 is a Matricellular regulator of angiogenesis.” PLoS One 5(11).
Williams, K. E., *Fulford, L.A., Albig, A.R. (2010). Lumican Reduces Tumor Growth Via Induction of Fas-Mediated Endothelial Cell Apoptosis. Cancer Microenvironment 4(1): 115-126.